uric acid has been researched along with thalidomide in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Fricker, J | 1 |
Afridi, F; Kar, P; King-Morris, K; Komarla, A; Perrone, D | 1 |
Boggio, E; Bruna, R; Crisà, E; De Paoli, L; Dianzani, U; Gaidano, G; Gigliotti, L; Margiotta Casaluci, G; Moia, R; Patriarca, A; Rolla, R | 1 |
Ali, M; Ali, Z; Ismail, M; Khan, MTM; Rani, GF; Rehman, IU | 1 |
1 trial(s) available for uric acid and thalidomide
Article | Year |
---|---|
Long-term clinical efficacy and safety of thalidomide in patients with transfusion-dependent β-thalassemia: results from Thal-Thalido study.
Topics: beta-Thalassemia; Ferritins; Humans; Hydroxyurea; Thalidomide; Treatment Outcome; Uric Acid | 2023 |
3 other study(ies) available for uric acid and thalidomide
Article | Year |
---|---|
50th ASH Annual Meeting.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Humans; Lenalidomide; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Nadroparin; Rituximab; Thalidomide; Thromboembolism; Uric Acid | 2009 |
Proximal Renal Tubular Acidosis (Fanconi Syndrome) Induced by Apremilast: A Case Report.
Topics: Acidosis; Acidosis, Renal Tubular; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Psoriatic; Fanconi Syndrome; Humans; Hypokalemia; Male; Proteinuria; Thalidomide; Uric Acid | 2017 |
Anti-rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activity.
Topics: Acute Kidney Injury; Aged; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Bortezomib; Dexamethasone; Female; Humans; Multiple Myeloma; Prognosis; Thalidomide; Urate Oxidase; Uric Acid | 2020 |